Skip to main content

Table 1 Demographic and clinical characteristics of participants at baseline

From: Live birth rate after human chorionic gonadotropin priming in vitro maturation in women with polycystic ovary syndrome

Characteristics

Participants (n = 921)

Age, years

28.9 ± 3.5

Body mass index, kg/m2

21.8 ± 3.1

Anti-Müllerian hormone, ng/mL

12.3 ± 3.6

Antral follicle count, n

34.3 ± 18.3

Follicle-stimulating hormonea, IU/mL

8.5 ± 1.9

Progesteronea, ng/mL

0.7 ± 1.8

Luteinizing hormonea, IU/L

14.3 ± 6.9

Free testosterone indexa

5.2 ± 4.7

Menstrual cycles, n (%)

 Amenorrhea

52 (5.6)

 Oligomenorrhea

850 (92.3)

 Regular

19 (2.0)

Polycystic ovaries on ultrasound, n (%)

 Both ovaries

777 (84.4)

 One ovary

144 (15.6)

Duration of infertility, years

3.7 ± 2.6

Type of infertility, n (%)

 Primary

747 (81.1)

 Secondary

174 (18.9)

Number of IVF attempts, n, (%)

 1

814 (88.4)

 2

80 (8.7)

 3

27 (2.9)

Indications for IVM, n (%)

 Tubal factors

18 (2.0)

 Male factors

13 (1.4)

 Ovulation induction failure

862 (93.6)

 Previous OHSS with COH

18 (2.0)

 Other

10 (1.1)

  1. Values are mean ± standard deviation, or number of women (%)
  2. COH, controlled ovarian hyperstimulation, IVF in vitro fertilization, IVM in vitro maturation, OHSS ovarian hyperstimulation syndrome
  3. aHormone levels were assessed at the first physician visit, on the second day of progestogen-induced bleeding